文献速递胃肠外科围术期管理与 ERAS

重新定义无并发症减重手术后常规术后血液检查的角色

Redefining the role of routine postoperative bloodwork following uncomplicated bariatric surgery.
PubMed 文献 · Surg Endosc · 2022-08-11

该质量改进项目对无并发症的择期减重手术患者,仅在围术期临床担忧、胰岛素依赖型糖尿病或治疗性抗凝时进行术后第1天(POD1)血液检查,并与常规检查的历史对照组比较。结果显示干预组输血、二次手术及30天急诊就诊率无显著差异,且节省了实验室处理费用和试管。

要点

  • 无临床担忧的减重手术患者可安全避免POD1血液检查。
  • 干预组与对照组在输血、二次手术和30天急诊就诊率上无显著差异。
  • 避免POD1血液检查节省了约6602.24美元实验室处理费和512个试管。

核心结论

  • 在无临床担忧的情况下,POD1血液检查可安全避免,不显著增加术后并发症,并带来财务、环境及患者不适方面的益处。

研究设计与样本

  • 质量改进项目,干预组为2020年9月至2021年4月接受减重手术的患者303例,对照组为2020年9月前常规进行POD1实验室检查的减重手术患者。

主要发现

  • 干预组303例中,256例(84.5%)未进行POD1血液检查,12例(3.9%)违反方案进行血液检查但无一改变管理。
  • 35例(12%)适当订购血液检查的患者中,6例(2%)需输血,2例(0.7%)因出血在同次住院需二次手术。
  • 干预组与对照组在输血率、二次手术率或30天急诊就诊率方面无显著差异。
  • 避免POD1血液检查节省约6602.24美元实验室处理费和512个试管。

关键数值与推荐

  • POD1血液检查仅用于围术期临床担忧、胰岛素依赖型糖尿病或治疗性抗凝患者。

临床怎么用

  • 对于无临床担忧的择期减重手术患者,可不常规进行POD1血液检查,以减少低价值护理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A quality improvement opportunity was identified to de-adopt the low-value care practice of routinely performing bloodwork for all patients undergoing elective bariatric surgery. While these patients are typically discharged on postoperative day 1 (POD1) after bloodwork is performed, it is uncommon for the discharge plan to change due to unexpected laboratory abnormalities alone. METHODS: Patients undergoing bariatric surgery between September 2020 and April 2021 only had POD1 bloodwork if there were perioperative clinical concerns, they had insulin-dependent diabetes, or they were therapeutically anticoagulated. Thirty-day Emergency Department (ED) visits and readmissions were monitored as balancing measures. Outcomes were compared to a control group that underwent bariatric surgery prior to September 2020 when POD1 laboratory testing was routinely performed. Financial and environmental costs were estimated based our institutional standards. RESULTS: The intervention group consisted of 303 patients: 248 (82%) Roux-en-Y gastric bypasses and 55 (18%) sleeve gastrectomies. Most patients (n = 256, 84.5%) did not have POD1 bloodwork. Twelve (3.9%) had bloodwork performed in violation of our protocol, of which none had a change in management based on the results. Of the 35 (12%) who had appropriately ordered bloodwork, 6 (2%) required a transfusion and 2 (0.7%) required a second surgery on the same admission for hemorrhage. Forty-four (14.5%) had 30-day ED visits of which 17 (5.6%) were within 7 days. Sixteen (5.3%) were readmitted. There were no significant differences between intervention and control groups in the rate of transfusion, second surgery, or 30-day ED visits. The avoidance of POD1 bloodwork saved approximately $6602.24 in lab processing fees alone and 512 test tubes. CONCLUSION: POD1 bloodwork can be safely avoided in the absence of clinical concerns. In addition to not significantly increasing postoperative complications, there were benefits from a financial cost, environmental impact, and patient discomfort perspective.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Selvam R, Jarrar A, Meghaizel C, et al. Redefining the role of routine postoperative bloodwork following uncomplicated bariatric surgery. Surg Endosc. 2022. PMID: 35951121. doi:10.1007/s00464-022-09518-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。